Ranny Yaffe
Algemeen Directeur bij VESSL Therapeutics Ltd.
Profiel
Ranny Yaffe is currently the Co-Chief Executive Officer at VESSL Therapeutics Ltd.
He started this position in 2020.
Prior to his current role, Mr. Yaffe obtained an undergraduate degree and an MBA from Technion-Israel Institute of Technology.
Actieve functies van Ranny Yaffe
| Bedrijven | Functie | Begin |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Algemeen Directeur | 01-01-2020 |
Opleiding van Ranny Yaffe
| Technion-Israel Institute of Technology | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
